Временное руководство
21 марта 2020 г.
ВОЗ опубликовала руководство по лабораторному тестированию случаев, подозреваемых на COVID-19. Принимая во внимание тот факт, чт...о глобальное распространение COVID-19 привело к резкому увеличению количества подозреваемых случаев заболевания и географических зон, в которых необходимо проводить лабораторные исследования, наращивание объемов молекулярного тестирования на COVID-19 привело к дефициту реагентов для молекулярного тестирования на COVID-19 и других методов молекулярной диагностики во всем мире. Помимо проблем с поставками, во многих регионах, особенно в странах с низким и средним уровнем дохода, существуют значительные ограничения в плане возможности освоения иностранной помощи.
more
Временные рекомендации
17 марта 2020 г.
Данный документ представляет собой адаптированную версию временных рекомендаций, разработанных для ближневосточного респ...ираторного синдрома, вызванного коронавирусом (БВРС-КоВ), которые были опубликованы в июне 2018 г.1, и был составлен на основе опубликованных ВОЗ научно обоснованных рекомендаций, включая руководство «Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care» (Профилактика инфекций и борьба с острыми респираторными инфекциями, способными вызывать эпидемии и пандемии, при оказании медико-санитарной помощи)2, а также имеющейся на сегодняшний день информации о COVID-19.
more
Проект – 24 января 2020 г.
WHO/2019-nCoV/Readiness/v2020.2
Accessed: 02.05.2020
Coronaviruses are a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).
Scientific Brief, 17 June 2020
Step Up for TB 2020 Tuberculosis Policies in 37 Countries A survey of prevention, testing, and treatment policies and practices.
The country scorecard reflects how many of 14 internationally recommended key policies are in place at the national level, based on the Step Up for TB 2020 report survey....
more
Lancet 2020 ; 396 : 1829-40
Lancet Glob Health 2020 Published Online October 22, 2020 https://doi.org/10.1016/S2214-109X(20)30325-9
Infection and Drug Resistance 2020:13 4047–4060
International Journal of Advances in Medicine. Vol. 7 No. 7 (2020): July 2020 . This study explores the clinical characteristics and outcomes of patients with concurrent malaria and HIV infection, a combination that is relatively understudied in India.
BMC Pregnancy Childbirth 20, 379 (2020). https://doi.org/10.1186/s12884-020-03064-x
2020 was a year like no other. Amidst on-going humanitarian crises, largely fuelled by conflict and violence but also driven by the effects of climate change – such as the largest locust infestation in a generation – the world had to contend with a global pandemic. In less than one year (March-D...ecember 2020), more than 82 million COVID-19 cases and 1.8 million deaths were recorded. In that timeframe, out of the global COVID-19 totals, 30 per cent of COVID-19 cases and 39 per cent deaths were recorded in GHRP countries.
more
January 2020 to December 2021
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...COVERY and REMAP-CAP randomised controlled trials triggered this guideline update, resulting in a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19.
Prior recommendations: (a) A recommendation not to use ivermectin in patients with covid-19, regardless of disease severity, except in the context of a clinical trial; (b) a strong recommendation against the use of hydroxychloroquine in patients with covid-19, regardless of disease severity; (c) a strong recommendation against the use of lopinavir-ritonavir in patients with covid-19, regardless of disease severity; (d) a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19; (e) a conditional recommendation against systemic corticosteroids in patients with non-severe covid-19; and (f) a conditional recommendation against remdesivir in hospitalised patients with covid-19.
more
Воздействие COVID-19 на пожилых людей в странах с низким и средним уровнем доходов – выводы за 2020 годРезюме
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr...eased, unemployment has soared, and access to health care for the poorest and most vulnerable has been cut. COVID-19 has made people less likely to seek health care because they are afraid of getting infected with the virus. Fear and uncertainty surrounding COVID-19 have also increased stigma and discrimination. As frontline workers without enough access to personal protective equipment (PPE) risk their lives to treat patients, the virus pushes already fragile health systems to the brink.
more
9 Dec 2020
Available in English, Afrikaans, isiXhosa